Vivos (RDGL) Enterprise Value Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vivos | - | - | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -11.52% |
| Sep 30, 2025 | -171.48% |
| Jun 30, 2025 | -60.62% |
| Dec 31, 2024 | -155.35% |
| Sep 30, 2024 | -50.35% |
| Jun 30, 2024 | -189.35% |
| Mar 31, 2024 | -100.99% |
| Dec 31, 2023 | -210.76% |
| Mar 31, 2023 | -875.37% |
| Dec 31, 2022 | -190.01% |
| Sep 30, 2022 | -145.90% |
| Jun 30, 2022 | -23.25% |
| Mar 31, 2022 | -120.01% |
| Dec 31, 2021 | -124.94% |
| Sep 30, 2021 | -957.80% |
| Jun 30, 2021 | -552.51% |
| Mar 31, 2021 | -58.90% |
| Dec 31, 2020 | -38.24% |
| Sep 30, 2020 | -15.09% |
| Jun 30, 2020 | -56.83% |
| Dec 31, 2019 | -151.39% |
| Sep 30, 2019 | -153.15% |
| Jun 30, 2019 | 41.70% |
| Mar 31, 2019 | 14.53% |
| Mar 31, 2018 | 81.17% |
| Dec 31, 2017 | -5.34% |
| Sep 30, 2017 | 14.14% |
| Jun 30, 2017 | -92.87% |
| Dec 31, 2016 | 11.90% |
| Sep 30, 2016 | 75.95% |
| Jun 30, 2016 | 48.66% |
| Dec 31, 2015 | 21.20% |
| Sep 30, 2015 | 57.85% |
| Jun 30, 2015 | 12.57% |